Format

Send to

Choose Destination
Semin Cancer Biol. 2004 Aug;14(4):283-94.

DAP-kinase as a target for drug design in cancer and diseases associated with accelerated cell death.

Author information

1
Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel. shanib@weizmann.ac.il

Abstract

Misregulated cell death, which can result in either the excessive, inappropriate elimination of cells, or in the insufficient removal of damaged or malignant cells, has been associated with numerous diseases. Here we discuss an important molecular regulator of cell death, DAP-kinase (DAPk), which presents a promising target for therapeutic intervention. A structure-functional analysis of this calcium-regulated Ser/Thr kinase which promotes cell death will be presented, and emphasis will be placed on particular disease models in which its modulation might affect clinically-relevant cell death processes.

PMID:
15219621
DOI:
10.1016/j.semcancer.2004.04.008
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center